Compare LAES & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAES | CYRX |
|---|---|---|
| Founded | 2022 | 1999 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.0M | 438.7M |
| IPO Year | N/A | N/A |
| Metric | LAES | CYRX |
|---|---|---|
| Price | $4.21 | $9.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $6.00 | ★ $12.83 |
| AVG Volume (30 Days) | ★ 14.3M | 594.0K |
| Earning Date | 12-11-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | $10,978,000.00 | ★ $243,795,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.26 |
| P/E Ratio | ★ N/A | $7.44 |
| Revenue Growth | N/A | ★ 41.27 |
| 52 Week Low | $1.48 | $4.58 |
| 52 Week High | $11.00 | $11.44 |
| Indicator | LAES | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 49.73 |
| Support Level | $4.45 | $9.08 |
| Resistance Level | $5.09 | $10.30 |
| Average True Range (ATR) | 0.38 | 0.46 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 33.59 | 42.94 |
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.